As on Wednesday, Cabaletta Bio Inc (NASDAQ: CABA) started slowly as it slid -2.70% to $12.96, before settling in for the price of $13.32 at the close. Taking a more long-term approach, CABA posted a 52-week range of $7.69-$26.35.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was -26.63%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -15.09%. This publicly-traded company’s shares outstanding now amounts to $47.82 million, simultaneously with a float of $39.14 million. The organization now has a market capitalization sitting at $625.19 million. At the time of writing, stock’s 50-day Moving Average stood at $19.10, while the 200-day Moving Average is $17.27.
Cabaletta Bio Inc (CABA) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Cabaletta Bio Inc’s current insider ownership accounts for 18.86%, in contrast to 85.54% institutional ownership. According to the most recent insider trade that took place on Jan 19 ’24, this organization’s insider sold 11,000 shares at the rate of 19.59, making the entire transaction reach 215,439 in total value, affecting insider ownership by 20,000. Preceding that transaction, on Dec 19 ’23, Company’s insider sold 11,000 for 21.89, making the whole transaction’s value amount to 240,789. This particular insider is now the holder of 20,000 in total.
Cabaletta Bio Inc (CABA) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 12/31/2023, the company posted -0.45 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.48) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
Cabaletta Bio Inc’s EPS decrease for this current 12-month fiscal period is -15.09% and is forecasted to reach -2.09 in the upcoming year.
Cabaletta Bio Inc (NASDAQ: CABA) Trading Performance Indicators
Let’s observe the current performance indicators for Cabaletta Bio Inc (CABA). It’s Quick Ratio in the last reported quarter now stands at 15.29. The Stock has managed to achieve an average true range (ATR) of 1.11.
In the same vein, CABA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.66, a figure that is expected to reach -0.48 in the next quarter, and analysts are predicting that it will be -2.09 at the market close of one year from today.
Technical Analysis of Cabaletta Bio Inc (CABA)
Through scrutinizing the latest numbers posted by the [Cabaletta Bio Inc, CABA], it can be observed that its last 5-days Average volume of 1.0 million was better the volume of 0.94 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 5.71% While, its Average True Range was 1.05.
Raw Stochastic average of Cabaletta Bio Inc (CABA) in the period of the previous 100 days is set at 0.59%, which indicates a major fall in contrast to 1.30% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 69.69% that was higher than 68.74% volatility it exhibited in the past 100-days period.
